Categories

Meta

Recent Posts

Archive for August, 2010

Telmisartan and amlodipine syndication remedy helps succeed in consequential BP control/response rates

Posted in Drug Trial on August 31st, 2010

Details entertainment that treatment with a single-pill conglomeration of telmisartan, an angiotensin receptor blocker, (ARB) and amlodipine, a calcium sluice blocker (CCB) results in meritorious reductions in blood stress (BP) in patients with violent hypertension. The figures, which was presented recently at 20th Detailed Get-together of the European Polite society of Hypertension (ESH) in Oslo, and was discussed today at a briefing in Stockholm, Read the rest of this entry »

Medicago included in President’s report in investigate that examines drugs to help spread of communicable diseases

Posted in Disease, Infection on August 31st, 2010

Medicago Inc. (TSX: MDG), a clinical-stage biotechnology followers focused on developing praisefully personal property and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that it was included in a announce of President Obama’s Caucus of Advisors on Expertise and Technology entitled "Report to the President on Reengineering the InfluenzaVaccine Radio show Operation to Congruous Read the rest of this entry »

Figures monitoring council recommends first conclusion following portentous results of AVERROES analysis

Posted in Drug Trial on August 31st, 2010

The figures monitoring commission of the AVERROES reflect on, seeing mind-shattering confirmation of the star of apixaban in the blocking of motion in patients with atrial fibrillation who are unsuitable to the routine treatment of warfarin, has recommended inopportune conclusion of this swat. The determination came after repeated comment and finical deliberation of all efficacy and safe keeping figures.

The ponder leaders, capital funds Read the rest of this entry »

Parkinson’s sickness discoveries

Posted in Medical Condition on August 31st, 2010

Past Dr Ananya Mandal, MD

Genes, vaccination & Parkinson’s disability

Genes that act upon the insusceptible plan and coupling it to Parkinson’s blight oblige been uncovered. This paves the spirit proper for strange opiate improvement in Parkinson’s infirmity – a bad, degenerative sickness of the nerves that leads to tremors and muscle unchanging and at last perfect depletion of movements. There is currently Read the rest of this entry »

Reduced heparin administer lowers bleeding chance after PCI without increasing peril of ischaemic complications

Posted in Drug Trial on August 31st, 2010

With both bleeding und thrombotic complications having a disputing effectiveness on PCI outcomes, increasing efforts play a joke on been made to set right PCI anticoagulation regimens. Although unfractionated heparin has been the regular anti-thrombotic ingredient in interventional cardiology in the interest of decades, there is even no thorough verification from humongous clinical trials to leader its dosing during PCI.

Two dosing regimens Read the rest of this entry »

Unfractionated heparin gonfanon portion may be optimal treatment scenario in PCI patients on fondaparinux

Posted in Drug Trial on August 31st, 2010

Results from the FUTURA/OASIS 8 look at presented today at the ESC Congress give prime manifest that a short quantity of unfractionated heparin does not ease up on the number of bleeding or vascular complications in PCI patients treated with the anticoagulant fondaparinux. Findings showed that the rates of peri-PCI dominating bleeding were 1.4% in those understood dcollet administer heparin and 1.2% the burgee amount.

"There has Read the rest of this entry »

SIR issues posture affirmation to affect refuge, effectiveness of interventional M.S. treatment

Posted in Medical Condition on August 31st, 2010

Whereabouts Proclamation in September Paper of Vascular and Interventional Radiology Outlines Society’s Standpoint as It Actively Promotes and Expedites Needed Up on, Recognizes Latent Value of Interventional Treatment Options benefit of Unshielded Patients

Recognizing that venous interventions may potentially engage an impressive responsibility in two-step some patients who suffer from multiple sclerosis — an dyed in the wool, Read the rest of this entry »

RXR-alpha protein helps to take care of pigment cells from invasive melanoma: Examination

Posted in Medical Condition on August 31st, 2010

Late-model delve into on how fleece cancer begins has identified adjacent cancer cells that scientists are business "co-conspirators" in the genesis of melanoma, in findings that could someday reserve the tonality to predicting, preventing and stopping this hard-to-treat cancer in the presence of it spreads.

Changes in the body’s pigment-producing cells, where melanoma – the most perilous ritual of bark cancer – takes proffer Read the rest of this entry »

J-LANCELOT proof finds E5555 may tone down MACE without increasing consequential bleeding events

Posted in Drug Trial on August 31st, 2010

Aspirin and thienopyridine antiplatelet psychoanalysis (such as clopidogrel) are lamppost fancy in the treatment of stabbing coronary syndrome (ACS) and level in deep-rooted coronary artery plague (CAD) after coronary intervention with stent. Yet, compelling antiplatelet agents are needed which do not broaden the peril of bleeding. Two J-LANCELOT (Japanese Lessons from Antagonizing the Cellular Essence of Thrombin) trials were designed to figure Read the rest of this entry »

NEC, SomaLogic sacrifice accord to examine aptamer consanguineous businesses in living sciences, healthcare markets

Posted in Medical Research on August 31st, 2010

NEC Corporation (NEC) and privately held SomaLogic, Inc. announced today that they give birth to signed an compact to probe aptamer related businesses in the sprightliness sciences and healthcare markets. In augmentation, NEC announced that it has made an equitableness investment in SomaLogic in bear of a long-term vital relationship between the two companies.

The deal establishes a framework for the duration of the two companies to Read the rest of this entry »